Article

Screening for trisomy 13 by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestation

2000-05-01

Abstract excerpt

In 42 cases of trisomy 13 at 10–14 weeks of gestation, compared with 947 controls, the median multiple of the median (MoM) of maternal serum free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein A (PAPP-A) was significantly decreased (0.506 MoM and 0.248 MoM respectively), whilst fetal nuchal translucency was increased (2.872 MoM). In 38% and 71% of cases of trisomy 13 maternal serum...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eb712c70-f72f-5cde-9c8e-a0d8f10cb015
DOI: 10.1002/(sici)1097-0223(200005)20:5<411::aid-pd822>3.0.co;2-2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Screening for trisomy 13 by fetal nuchal translucency and maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationDOI 10.1002/(sici)1097-0223(200005)20:5<411::aid-pd822>3.0.co;2-2Read

Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10-14 weeks of gestationSemantic proximity Read

Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancySemantic proximity Read

A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β‐hCG and PAPP‐ASemantic proximity Read

Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancySemantic proximity Read

Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestationSemantic proximity Read

The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free ?-hCG and PAPP-A at 10-14 weeks of gestationSemantic proximity Read

First‐trimester combined screening for trisomy 21 at 7–14 weeks' gestationSemantic proximity Read

Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non‐invasive prenatal testing?Semantic proximity Read

Maternal serum pregnancy‐associated plasma protein a and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancySemantic proximity Read

A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐ASemantic proximity Read

Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestationSemantic proximity Read

Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐ASemantic proximity Read